new screening recommendations for patients who have taken Redux or Pondimin (fenfluramine)
December 1997
The CDC just announced new screening recommendations for patients who have taken Redux or Pondimin (fenfluramine)...to identify patients who are at risk of getting bacterial endocarditis.
They're urging ALL patients who have taken these diet pills to get a physical exam...and possibly a echocardiogram...to rule out valve damage.
Previously, this was recommended only for SYMPTOMATIC patients.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote